Bricanyl Durules نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

bricanyl durules

astrazeneca limited - terbutaline sulfate 7.5mg - modified release tablet - 7.5 mg - active: terbutaline sulfate 7.5mg excipient: colloidal silicon dioxide ethylcellulose polyvinyl chloride stearyl alcohol tartaric acid

Bricanyl® 2.5mg Tablet الفلبين - الإنجليزية - FDA (Food And Drug Administration)

bricanyl® 2.5mg tablet

astrazeneca pharmaceuticals (phils.), inc.; distributor: astrazeneca pharmaceuticals (phils.), inc. - terbutaline sulfate - tablet - 2.5mg

BRICANYL TAB 5 MG TABLET كندا - الإنجليزية - Health Canada

bricanyl tab 5 mg tablet

astrazeneca canada inc - terbutaline sulfate - tablet - 5mg - terbutaline sulfate 5mg - selective beta 2-adrenergic agonists

BRICANYL TAB 2.5 MG TABLET كندا - الإنجليزية - Health Canada

bricanyl tab 2.5 mg tablet

astrazeneca canada inc - terbutaline sulfate - tablet - 2.5mg - terbutaline sulfate 2.5mg - selective beta 2-adrenergic agonists

Bricanyl Turbuhaler نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

bricanyl turbuhaler

astrazeneca limited - terbutaline sulfate 0.25mg; terbutaline sulfate 200ug equivalent to 0.25 mg metered dose - powder for inhalation - 0.25 mg/dose - active: terbutaline sulfate 0.25mg terbutaline sulfate 200ug equivalent to 0.25 mg metered dose excipient: lactose monohydrate - relief of bronchospasm occurring in bronchial asthma, bronchitis and other bronchopulmonary conditions where bronchospasm is a complicating factor. acute prophylaxis in situations known to induce bronchospasm, e.g. exercise induced asthma.